amphastar.com (AMPH) Company Sales Revenue

amphastar.com - graphic logo of issuer AMPH

Amphastar Pharmaceuticals (AMPH) is scaling sales of complex injectables, leveraging its leadership in the antidotes and high-precision generics segment. On GURU.Markets, this line chart of the company's sales performance clearly demonstrates revenue dynamics, where the value 0.75 records the metric level. Business stability is supported by a staff of top-tier chemical technologists who create unique dosage forms.

Amphastar Pharmaceuticals (AMPH): Company Revenue from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for Amphastar (AMPH)

- market price and analyst price targets:
Summary company analysis:AMPH, amphastar.com
Manufactured products of Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals (AMPH) sales measure the actual cash inflow velocity, excluding market speculation. Professional investors utilize this flow to identify anomalous deviations from the normal distribution of revenue. By analyzing the volatility of Amphastar Pharmaceuticals (AMPH) sales, one can forecast risks of a sharp contraction in demand or an impending correction. This price action confirms the effectiveness of production scaling. The robotization of filling lines and automated ampoule purity control should stabilize this metric.

Analysis of competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|PCRX (Pacira BioSciences) - Company Sales Revenue|Revenue and Sales Volume SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Company Revenue|Aquestive Corp - Revenue and Sales Volume|scpharmaceuticals.com (SCPH) - Company Sales|TECX: Revenue and Sales Volume|Tonix Pharmaceuticals - Company Sales Revenue|Company Sales SXTC|EPRX: Company Sales Revenue|Company Sales BHST (BioHarvest Sciences Inc.)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP